Patent details

Basic Information

Publication number:

EP1586337

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP052523156

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque

French Title of Invention:

Administration locale d'une combinaison de rapamycine et 17 beta-estradiol pour le traitement de plaque vulnérable

German Title of Invention:

Lokale Verabreichung einer Kombination von Rapamycin und 17 beta-Estradiol zur Behandlung von vulnerabler Plaque

SPC Number:

Dates

Filing date:

14/04/2005

Grant date:

21/06/2017

EP Publication Date:

19/10/2005

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/06/2017

EP B1 Publication Date:

21/06/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2018

Expiration date:

14/04/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/06/2017

 

 

Name:

Cordis Corporation

Address:

14201 N.W. 60th Avenue, Miami Lakes, Florida 33014, United States (US)

Inventor

Name:

Falotico, Robert

Address:

United States (US)

Priority

Priority Number:

826058

Priority Date:

15/04/2004

Priority Country:

United States (US)

Classification

IPC classification:

A61L 31/16; A61F 2/91;

Publication

European Patent Bulletin

Issue number:

201725

Publication date:

21/06/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1